Recipharm named Vikas Gupta as President of its recently renamed biologics business arm. Gupta joins ReciBioPharm from Repligen, where he was Vice President & General Manager, Gene Therapy and Downstream Bioprocessing. The appointment comes as Recipharm officially renames its biologics business division after the acquisitions of Arranta Bio, GenIbet and Vibalogics.
1st Jan change | Capi. | |
---|---|---|
+5.34% | 7.1TCr | |
+23.95% | 903.49Cr | |
-22.81% | 438.38Cr | |
+14.83% | 426.88Cr | |
+19.21% | 372.53Cr | |
+0.06% | 198.88Cr | |
+8.78% | 196.5Cr | |
-36.94% | 187.16Cr | |
-45.25% | 170.78Cr |